Table 2.
Parameters | Control | Cinnamon oil (200 mg/kg b.w.) | APAP | APAP + Cinnamon oil (mg/kg b.w.) |
||
---|---|---|---|---|---|---|
50 | 100 | 200 | ||||
ALT (IU/L) | 34.28 ± 2.34 | 24.64 ± 1.67 | 358.95 ± 24.11*** | 133 ± 19.81### | 130.43 ± 13.37### | 64 ± 10.09### |
AST (IU/L) | 12.5 ± 2.13 | 12.67 ± 1.65 | 16.5 ± 3.21** | 15.25 ± 3.11 | 14 ± 0.98# | 13.5 ± 0.76## |
ALP (IU/L) | 186.3 ± 24.45 | 178 ± 21.85 | 302.5 ± 22.37*** | 196 ± 19.65## | 163 ± 9.08### | 41.33 ± 7.59### |
Bilirubin | 2.35 ± 0.76 | 2.28 ± 0.12 | 3.06 ± 1.2* | 2.13 ± 0.09# | 0.66 ± 0.17### | 0.18 ± 0.06### |
Albumin | 0.80 ± 0.03 | 0.73 ± 0.12 | 0.86 ± 1.04ns | 0.83 ± 0.11ns | 0.81 ± 0.87ns | 0.78 ± 0.09ns |
Total protein (g/dL) | 1.017 ± 0.19 | 0.98 ± 1.09 | 1.57 ± 0.98ns | 1.54 ± 0.46ns | 1.42 ± 1.76ns | 1.36 ± 1.18ns |
Estimation of tissue homogenate biomarkers in APAP induces hepatotoxicity in rats. CO treatment significantly reveres the markers in APAP + CO group as compared to the APAP group. Values are expressed as mean ± S.E.M of n = 6 animals. Significance was determined by one-way ANOVA followed by Tukey-Kramer post-hoc test for multiple comparisons. (ns = non-significant).
*p < 0.05; **p < 0.01; ***p < 0.001 APAP vs. control.
#p < 0.05; ##p < 0.01, ###p < 0.001 APAP + CO vs. APAP.